BR100 No Change (0%)
BR30 No Change (0%)
KSE100 No Change (0%)
KSE30 No Change (0%)
AGHA 6.38 Increased By ▲ 0.06 (0.95%)
BECO 4.35 Increased By ▲ 0.08 (1.87%)
BML 62.55 Increased By ▲ 0.10 (0.16%)
BOP 31.39 Increased By ▲ 0.16 (0.51%)
CNERGY 11.73 Increased By ▲ 0.14 (1.21%)
CSIL 5.91 Increased By ▲ 0.19 (3.32%)
FCCL 61.71 Increased By ▲ 0.17 (0.28%)
FFL 14.79 Decreased By ▼ -0.23 (-1.53%)
FNEL 1.24 Increased By ▲ 0.01 (0.81%)
KEL 6.32 Increased By ▲ 0.06 (0.96%)
KOSM 5.90 Increased By ▲ 0.34 (6.12%)
LOTCHEM 24.69 Increased By ▲ 0.01 (0.04%)
MLCF 103.93 Decreased By ▼ -0.15 (-0.14%)
NBP 173.32 Decreased By ▼ -1.96 (-1.12%)
NCPL 51.83 Decreased By ▼ -0.94 (-1.78%)
NPL 54.03 Decreased By ▼ -0.09 (-0.17%)
OGDC 315.87 Increased By ▲ 2.48 (0.79%)
PACE 9.26 Increased By ▲ 0.06 (0.65%)
PAEL 35.58 Decreased By ▼ -0.22 (-0.61%)
PIBTL 13.66 Increased By ▲ 0.19 (1.41%)
PPL 226.07 Increased By ▲ 4.26 (1.92%)
PRL 80.28 Increased By ▲ 1.20 (1.52%)
PTC 46.64 Decreased By ▼ -0.21 (-0.45%)
SSGC 23.82 Decreased By ▼ -0.05 (-0.21%)
TBL 9.24 Decreased By ▼ -0.07 (-0.75%)
TELE 7.55 Increased By ▲ 0.16 (2.17%)
TPL 24.54 Decreased By ▼ -0.57 (-2.27%)
TPLP 12.99 Increased By ▲ 0.48 (3.84%)
TREET 25.98 Decreased By ▼ -0.27 (-1.03%)
TRG 53.33 Decreased By ▼ -0.11 (-0.21%)
By

LONDON: As many as 1 in 7 children may have symptoms linked to the coronavirus months after testing positive for Covid-19, the authors of an English study on long COVID in adolescents said on Wednesday.

Children rarely become severely ill with COVID-19 but they can suffer lingering symptoms, and the study is one of the largest of its kind on how common so-called long COVID is in the age group.

The study, led by University College London and Public Health England, found that 11- to 17-year-olds who tested positive for the virus were twice as likely to report three or more symptoms 15 weeks later than those who had tested negative.

Researchers surveyed 3,065 11- to 17-year-olds in England who had positive results in a PCR test between January and March, and a control group of 3,739 11- to 17-year-olds who tested negative over the same period.

EU says COVID boosters may have higher legal risks without EMA approval

Among those who tested positive, 14% reported three or more symptoms such as unusual tiredness or headaches 15 weeks later, compared with 7% reporting symptoms by that time among the control group.

The researchers said that while the findings suggested as many as 32,000 teenagers might have had multiple symptoms linked to COVID-19 after 15 weeks, the prevalence of long COVID in the age group was lower than some had feared last year.

"Overall, it's better than people would've guessed back in December," Professor Terence Stephenson of the UCL Great Ormond Street Institute of Child Health, told reporters.

Antibodies from Sinovac's Covid-19 shot fade after about 6 months, booster helps

The findings were a pre-print which had not been peer-reviewed. The authors said that any decision to extend vaccination to 12- to 15-year-olds in Britain was unlikely to be based on this study as there was not enough data on whether vaccination protects against long COVID.

"We are getting increasing evidence on the safety of the vaccine in the 12- to 15-year-olds and that's more likely to be taken into consideration," Liz Whittaker, a paediatrician at Imperial College London, told reporters.

Comments

Comments are closed for this article.